Fox Chase Cancer Center News

PHILADELPHIA (August 5, 2020)—In a study published online today, researchers from Fox Chase Cancer Center and Temple University used a novel approach to analyzing cancer survival disparities in relation to residence by incorporating residential mobility.

PHILADELPHIA (August 4, 2020)–Physicians at Fox Chase Cancer Center have published an editorial outlining how they conducted virtual recruiting interviews for their surgical oncology fellowships, a publication they say is one of the first of its kind.

PHILADELPHIA (July 29, 2020)—Researchers at Fox Chase Cancer Center have determined that the protein NeuroD1 promotes cell differentiation in medulloblastoma, a finding that could help researchers develop novel cancer treatments.

PHILADELPHIA (July 28, 2020) – Fox Chase Cancer Center announces the hiring of Elizabeth A. Bourne, DO, who will join the Department of Medicine as an assistant professor in the Division of Hospitalist Medicine.

PHILADELPHIA (July 27, 2020)—Researchers at Fox Chase Cancer Center found in a recent study that older patients who underwent chemoradiation therapy followed by removal of their esophagus due to cancer had toxicities and outcomes similar to younger patients.

PHILADELPHIA (July 27, 2020)—In a recent review article, Fox Chase Cancer Center researchers outlined obstacles, research methods, and future treatment prospects for patients with Von Hippel-Lindau (VHL) disease.

PHILADELPHIA (July 22, 2020)—Researchers at Fox Chase Cancer Center have developed a new method for growing and storing medulloblastoma tumor cells, a step that could assist researchers in the development of new drugs. Stromal cells called astrocytes facilitate the signaling pathway that is associated with the formation of medulloblastoma, the most common type of malignant brain tumor found in children.

PHILADELPHIA (July 17, 2020) – Scientists at Fox Chase Cancer Center and Ben-Gurion University of the Negev (BGU) have received a new grant from the United States-Israel Binational Science Foundation (BSF) that will fund continuing research on an antibody developed as part of a longstanding collaboration between the two organizations.